0_Introduction Valentini.pdf |
1 |
1_Staging & response - esophageal ca_A Riddel |
23 |
2_Estro Oesophageal Surgery_Allum |
58 |
3_Esophageal RT Valentini |
119 |
4_Hendlisz ESTRO School STateoftheart combined modalities |
161 |
5_Hendlisz ESTRO School Chemo tox constraints |
191 |
6_Primary Tumor extension_Quaaas |
212 |
8_Esoph Ca- Prim & nodal subsites_Riddell |
269 |
9_Sub-site delineation_Maingon |
309 |
10_Verheij ESTRO Course Upper GI_oes_dose issues |
343 |
11_Dose constraints ESOPHAGUS Maingon |
370 |
12_CompetitivePlans_Verellen_2016 |
394 |
12a_Paranoid Target Volume_Verellen_2016 |
426 |
13_Esoph Ca- prim vs nodal recur_Riddell |
487 |
14_ESTRO OESOPHAGEAL RECURRENCE_Allum |
501 |
15_Verheij ESTRO Course Upper GI_oes_recurrences |
512 |
16_New in esophageal cancers_Maingon |
530 |
17_Gastric - Imaged based staging & Nodal sites_Riddel |
565 |
18_Estro Gastric Surgery_Allum |
574 |
19_Gastric RT Valentini |
618 |
20_Lordick_ESTRO.Brussels.2016_Gastric |
658 |
21_Estro Gastro_Quaas |
697 |
22a_Gastric - Imaged based staging & Nodal sites_Riddell |
719 |
22b_Gastric Ca- recurrence_Riddell |
771 |
23_ESTRO Recurrence Gastric Cancer_Allum |
780 |
24_ Cellini ESTRO Upper GI |
793 |
25 Verheij ESTRO Course Upper GI_gastric_dose issues_v2 |
838 |
26_Dose Constraints_Maingon |
867 |
27_Lordick_ESTRO.Brussels.2016_Chem.Tox |
894 |
28 VerheijESTRO Course Upper GI_gastric_new perspectives_v2 |
928 |